Design, Synthesis and Anticancer Activity of New Benzofuran-Chalcone Hybrids and Their Water Soluble Sodium Salts

dc.contributor.authorCinar-Asa, Sibel
dc.contributor.authorCoskun, Demet
dc.contributor.authorAkgun, Oguzhan
dc.contributor.authorAkgun, Halime
dc.contributor.authorCoskun, Mehmet Fatih
dc.contributor.authorAri, Ferda
dc.date.accessioned2026-08-12T17:20:46Z
dc.date.issued2023
dc.departmentFırat Üniversitesi
dc.description.abstractIn this study, firstly, 1-(7-ethoxy-1-benzofuran-2-yl) ethanone and 1,1'-(7-ethoxy-1-benzofuran-2,4-diyl)diethanone were synthesized for the starting reagent purposes. The synthesized benzofuran-chalcone salts were soluble in water at room temperature. Structural analysis of the synthesized compounds was characterized by elemental analysis, FT-IR and NMR spectroscopy techniques. The anticancer activities of the compounds were determined by SRB viability assay in human lung cancer (A549, H1299) and breast cancer (MCF-7, MDA-MB-231) cell lines. Findings for apoptosis were determined by flow cytometry analysis and the PARP-ELISA method. The results of the in vitro SRB analysis of the compounds showed that some of the chalcone hybrids were very effective on both types of cancer in a dose and time-dependent manner. Treatment of all cancer cell types with these hybrids resulted in a significant increase in the percentage of early and mainly late apoptotic cells, demonstrating their apoptosis-inducing effects via the Caspase 3/7 Activity.
dc.description.sponsorshipResearch Fund of TUBITAK (The Scientific and Technological Research Council of Turkey) [119Z727, 100/2000]; Council of Higher Education (CoHE); 100/2000 Council of Higher Education (CoHE)
dc.description.sponsorshipThis research received a grant from the Research Fund of TUBITAK (The Scientific and Technological Research Council of Turkey) with the project no 119Z727. Author Sibel Cinar-Asa is a 100/2000 The Council of Higher Education (CoHE) PhD Scholar in Molecular Pharmacology and Drug Investigations subdivision and author Oguzhan Akgun is a 100/2000 Council of Higher Education (CoHE) PhD Scholar in Translational Medicine subdivision.
dc.identifier.doi10.1002/slct.202204402
dc.identifier.issn2365-6549
dc.identifier.issue9
dc.identifier.orcid0000-0002-2048-3252
dc.identifier.orcid0000-0001-7141-6909
dc.identifier.orcid0000-0002-3064-6449
dc.identifier.scopus2-s2.0-85149519911
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.1002/slct.202204402
dc.identifier.urihttps://hdl.handle.net/11508/53680
dc.identifier.volume8
dc.identifier.wosWOS:000940798800001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherWiley-V C H Verlag Gmbh
dc.relation.ispartofChemistryselect
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectAnticancer activity
dc.subjectapoptosis
dc.subjectbenzofuran
dc.subjectchalcone
dc.subjectcytotoxicity
dc.titleDesign, Synthesis and Anticancer Activity of New Benzofuran-Chalcone Hybrids and Their Water Soluble Sodium Salts
dc.typeArticle

Dosyalar